| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.25 | 6e-07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |